Picture of Shanrong Biotechnology logo

SRBT — Shanrong Biotechnology Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Shanrong Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2007
July 31st
2008
July 31st
2008
December 31st
2009
December 31st
Period Length:8 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-0.053-0.04-2.72-5.08
Depreciation
Non-Cash Items00.0070.1523.38
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.03-0.0111.080.872
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.023-0.044-1.45-0.787
Capital Expenditures-0.0060-0.0010
Purchase of Fixed Assets
Cash from Investing Activities-0.0060-0.0010
Financing Cash Flow Items——-0.0250
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.07501.480.757
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.046-0.0450.027-0.031